Carbaglu (carglumic acid) — Medica

Initial criteria

• Patient’s plasma ammonia level is ≥ 50 micromol/L
• The medication is prescribed in conjunction with other ammonia-lowering therapies (e.g., intravenous glucose, insulin, L-carnitine, protein restriction, dialysis)
• The medication is prescribed by or in consultation with a metabolic disease specialist (or specialist who focuses in the treatment of metabolic diseases)

Approval duration

7 days